CURI vs NMAX
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 01, 2026
CURI
NMAX
Investment Advisor Scores
NMAX
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CURI | NMAX | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 9.2937 | 36.3636 | CURI |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 22.3% | 16.5% | CURI |
| Earnings Growth | 1400.0% | 0.0% | CURI |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 39.7/100 | 36.0/100 | CURI |
| Profit Margin | 0.0% | -3.1% | CURI |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | AVOID NEW MONEY | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CURI
MarkupPrice above SMA50, rising 50-day trend (2.8% over 20 days), RSI 53
NMAX
NeutralMixed signals - no dominant trend phase, RSI 37
Fundamentals Snapshot
| Metric | CURI | NMAX |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 9.4 | 44.3 |
| Trailing P/E | — | 58.1 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | 0.2% |
| Gross Margin | 0.6% | 0.4% |
| Operating Margin | 0.4% | 0.0% |
| EPS | -0.01 | 0.17 |
| Dividend Yield | 0.11% | — |